4 completed. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
Follow tanimilast: new trials by email Literature Review of tanimilast trials Research Report on tanimilast
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study to Investigate the Pharmacokinetics, Safety and Tolerability Following Single Administration of CHF6001 in Subjects With Mild, Moderate and Severe Liver Impairment in Comparison With Matched Healthy Control Subjects CHF6001 - Chronic Obstructive Pulmonary Disease | Phase 1 | Completed | Chiesi Farmaceutici S.p.A. | 44 | 2022-05-05 | 2024-04-15 |
| Evaluation of the Absolute Bioavailability and Mass Balance of CHF6001 (Tanimilast) in Healthy Subjects CHF6001 - Chronic Obstructive Pulmonary Disease (COPD), COPD | Phase 1 | Completed | Chiesi Farmaceutici S.p.A. | 8 | 2021-03-10 | 2024-03-18 |
| Pharmacokinetic Interaction and the Safety of Inhaled CHF5259 and CHF6001 CHF5259 and CHF6001, CHF5259 + placebo, CHF6001 + placebo - Copd | Phase 1 | Completed | Chiesi Farmaceutici S.p.A. | 36 | 2016-01-01 | 2016-12-29 |
| A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled CHF6001 Single Ascending Dose (SAD), Multiple Ascending Dose (MAD) - Chronic Obstructive Pulmonary Disease | Phase 1 | Completed | Chiesi Farmaceutici S.p.A. | 48 | 2014-11-01 | 2020-07-31 |
Pulmonary Disease, Chronic Obstructive (4)
Chiesi Farmaceutici S.p.A. (4)
United Kingdom (3) · Bulgaria (1)
Ronnie Beboso, MD (1) · Stuart Mair, MD (1)